These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7033674

  • 21. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation].
    Pfisterer M, Jockers G, Burkart F, Schmitt HE, Wolff G, Skarvan K, Stulz P, Hasse J, Grädel E.
    Schweiz Med Wochenschr; 1987 Oct 24; 117(43):1688-92. PubMed ID: 3501162
    [Abstract] [Full Text] [Related]

  • 22. Antiplatelet and anticoagulant therapy after coronary bypass.
    Phillips SJ, Kongtahworn C, Zeff RH, Beshany SE.
    N Engl J Med; 1980 Apr 10; 302(15):866. PubMed ID: 6965762
    [No Abstract] [Full Text] [Related]

  • 23. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E.
    Circulation; 1980 Dec 10; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract] [Full Text] [Related]

  • 24. Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin.
    Metke MP, Lie JT, Fuster V, Josa M, Kaye MP.
    Am J Cardiol; 1979 Jun 10; 43(6):1144-8. PubMed ID: 312596
    [Abstract] [Full Text] [Related]

  • 25. [Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
    Schöndorf TH.
    Med Welt; 1982 Jun 11; 33(23):851-4. PubMed ID: 7050615
    [No Abstract] [Full Text] [Related]

  • 26. [Controversy on platelet-inhibiting drugs].
    Oelz O.
    Schweiz Med Wochenschr; 1985 May 18; 115(20):703-7. PubMed ID: 3892659
    [Abstract] [Full Text] [Related]

  • 27. Role of platelet-active drugs in coronary artery disease.
    Sherry S.
    Cardiovasc Clin; 1983 May 18; 14(1):173-89. PubMed ID: 6352025
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
    Gitler B, Gitler ES.
    Am Heart J; 1983 Sep 18; 106(3):563-70. PubMed ID: 6410893
    [No Abstract] [Full Text] [Related]

  • 29. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Loeliger EA.
    Ned Tijdschr Geneeskd; 1993 Dec 18; 137(51):2669. PubMed ID: 8278004
    [No Abstract] [Full Text] [Related]

  • 30. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N, Wright J, Sturridge M, Pepper J, Magee P, Walesby R, Layton C, Honey M, Balcon R.
    Br Heart J; 1985 Feb 18; 53(2):201-7. PubMed ID: 3881108
    [Abstract] [Full Text] [Related]

  • 31. Coronary artery bypass and antiplatelet therapy.
    Copeland JG, Goldman S.
    Ariz Med; 1984 Apr 18; 41(4):223-5. PubMed ID: 6611146
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical prevention of thrombosis by antiplatelet agents].
    Latour JG.
    Union Med Can; 1979 Oct 18; 108(10):1168-86. PubMed ID: 392868
    [No Abstract] [Full Text] [Related]

  • 33. Use of common antiplatelet drugs for vascular diseases.
    Pagano T, Nair CK, Sketch MH.
    Geriatrics; 1983 Nov 18; 38(11):75-95. PubMed ID: 6605278
    [No Abstract] [Full Text] [Related]

  • 34. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Harker LA.
    Circulation; 1986 Feb 18; 73(2):206-23. PubMed ID: 3510760
    [Abstract] [Full Text] [Related]

  • 35. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P.
    G Ital Cardiol; 1982 Feb 18; 12(8):598-603. PubMed ID: 6762978
    [No Abstract] [Full Text] [Related]

  • 36. Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
    Chesebro JH, Steele PM, Fuster V.
    Postgrad Med; 1985 Jul 18; 78(1):48-50, 57-71. PubMed ID: 3160013
    [Abstract] [Full Text] [Related]

  • 37. [Anticoagulants vs. low-dose aggregation inhibitors in the prevention of perioperative occlusion of aortocoronary bypass grafts. Preliminary results of a prospective randomized study].
    Pfisterer M, Jockers G, Meier B, Schmitt HE, Stulz P, Hasse J, Grädel E, Burkart F.
    Helv Chir Acta; 1987 Feb 18; 53(4):497-500. PubMed ID: 3494713
    [No Abstract] [Full Text] [Related]

  • 38. The prevention of thrombosis.
    Bove LG.
    J Maine Med Assoc; 1974 Oct 18; 65(10):233-5. PubMed ID: 4610070
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
    de Gaetano G, Cerletti C, Bertelè V.
    Lancet; 1982 Oct 30; 2(8305):974-7. PubMed ID: 6127469
    [No Abstract] [Full Text] [Related]

  • 40. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.
    Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN, Griffith BP.
    J Thorac Cardiovasc Surg; 2006 Jan 30; 131(1):122-30. PubMed ID: 16399303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.